AMG-167

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAMG-167

Drug Alias NameAMG-167

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionSclerostin inhibitors

TargetsSclerostin

Therapy Area/IndicationsBone Diseases, Metabolic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsBone Diseases, Metabolic

ATC CodeN/A